This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Joint Stock Company "Biocad". Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Aleksandr Andreevich Gordeev
Introduction
Aleksandr Andreevich Gordeev is a notable inventor based in Izhevsk, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is characterized by a focus on innovative solutions for medical treatments.
Latest Patents
Gordeev holds a patent for a monoclonal antibody that binds specifically to GITR. This invention relates to biotechnology and includes antibodies or antigen-binding fragments, as well as their applications. The patent details a nucleic acid encoding the antibody, an expression vector, and methods for preparing the antibody. Furthermore, it discusses the use of this antibody in treating diseases or disorders associated with GITR.
Career Highlights
Gordeev is associated with Joint Stock Company "Biocad," where he continues to advance his research and development efforts. His work at Biocad has positioned him as a key player in the biotechnology sector, contributing to innovative treatments and therapies.
Collaborations
Some of his notable coworkers include Anastasia Nikolaevna Ishutinova and Sergei Andreevich Ageev. Their collaboration enhances the research environment and fosters innovation within the company.
Conclusion
Aleksandr Andreevich Gordeev's contributions to biotechnology, particularly through his patent on monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile